Blood samples
Pre-clinicalTerminated 0 views this week 0 watching💤 Quiet
Interest: 18/100
18
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Non-Alcoholic Fatty Liver Disease
Conditions
Non-Alcoholic Fatty Liver Disease, Chronic Kidney Diseases, PreDiabetes, Kidney Transplant
Trial Timeline
May 29, 2019 → Mar 31, 2022
NCT ID
NCT03866421About Blood samples
Blood samples is a pre-clinical stage product being developed by Novo Nordisk for Non-Alcoholic Fatty Liver Disease. The current trial status is terminated. This product is registered under clinical trial identifier NCT03866421. Target conditions include Non-Alcoholic Fatty Liver Disease, Chronic Kidney Diseases, PreDiabetes.
What happened to similar drugs?
0 of 4 similar drugs in Non-Alcoholic Fatty Liver Disease were approved
Approved (0) Terminated (0) Active (4)
Hype Score Breakdown
Clinical
3
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03866421 | Pre-clinical | Terminated |
Competing Products
20 competing products in Non-Alcoholic Fatty Liver Disease